Vital Farms' (VITL) Outperform Rating Reiterated at William Blair

Vital Farms (NASDAQ:VITL - Get Free Report)'s stock had its "outperform" rating restated by equities research analysts at William Blair in a research note issued to investors on Friday,RTT News reports. William Blair also issued estimates for Vital Farms' Q2 2025 earnings at $0.27 EPS, Q3 2025 earnings at $0.26 EPS, FY2025 earnings at $1.28 EPS and FY2026 earnings at $1.54 EPS.

Several other equities research analysts also recently commented on VITL. Craig Hallum began coverage on shares of Vital Farms in a research report on Friday, December 20th. They set a "buy" rating and a $50.00 target price on the stock. Telsey Advisory Group restated an "outperform" rating and issued a $52.00 price objective on shares of Vital Farms in a report on Friday. Jefferies Financial Group cut their target price on Vital Farms from $45.00 to $41.00 and set a "buy" rating on the stock in a report on Monday, November 11th. TD Cowen increased their price target on Vital Farms from $41.00 to $45.00 and gave the company a "buy" rating in a research note on Wednesday, January 8th. Finally, Stifel Nicolaus raised shares of Vital Farms from a "hold" rating to a "buy" rating and set a $44.00 target price for the company in a research report on Friday. Eight research analysts have rated the stock with a buy rating, According to MarketBeat, Vital Farms currently has an average rating of "Buy" and an average target price of $44.57.

Remove Ads

Vital Farms Price Performance

NASDAQ VITL traded down $0.40 on Friday, hitting $31.15. 1,249,170 shares of the company's stock were exchanged, compared to its average volume of 1,271,110. The stock has a 50-day moving average of $38.55 and a 200-day moving average of $35.72. The stock has a market cap of $1.36 billion, a price-to-earnings ratio of 27.81 and a beta of 0.90. Vital Farms has a 52 week low of $18.26 and a 52 week high of $48.41. The company has a current ratio of 3.24, a quick ratio of 2.81 and a debt-to-equity ratio of 0.04.

Vital Farms (NASDAQ:VITL - Get Free Report) last issued its earnings results on Thursday, February 27th. The company reported $0.23 EPS for the quarter, topping the consensus estimate of $0.15 by $0.08. Vital Farms had a return on equity of 22.29% and a net margin of 8.68%. The firm had revenue of $165.99 million during the quarter, compared to the consensus estimate of $160.32 million. Analysts expect that Vital Farms will post 1.11 earnings per share for the current year.

Insider Buying and Selling at Vital Farms

In other news, CMO Kathryn Mckeon sold 12,300 shares of the business's stock in a transaction that occurred on Friday, January 17th. The stock was sold at an average price of $44.05, for a total value of $541,815.00. Following the transaction, the chief marketing officer now owns 46,203 shares in the company, valued at $2,035,242.15. The trade was a 21.02 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Matthew Ohayer sold 24,000 shares of the business's stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $43.19, for a total value of $1,036,560.00. Following the completion of the transaction, the insider now directly owns 7,014,890 shares in the company, valued at approximately $302,973,099.10. This represents a 0.34 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 190,202 shares of company stock worth $7,855,957. Insiders own 27.60% of the company's stock.

Institutional Investors Weigh In On Vital Farms

Several large investors have recently made changes to their positions in VITL. Cim LLC increased its holdings in Vital Farms by 80.7% in the 4th quarter. Cim LLC now owns 12,433 shares of the company's stock worth $469,000 after acquiring an additional 5,554 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Vital Farms by 19.4% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 88,695 shares of the company's stock valued at $3,343,000 after acquiring an additional 14,432 shares during the period. Sapience Investments LLC grew its stake in Vital Farms by 15.2% during the fourth quarter. Sapience Investments LLC now owns 77,698 shares of the company's stock valued at $2,928,000 after acquiring an additional 10,235 shares in the last quarter. Raiffeisen Bank International AG bought a new position in Vital Farms in the 4th quarter valued at $892,000. Finally, Nuveen Asset Management LLC grew its position in shares of Vital Farms by 21.4% during the 4th quarter. Nuveen Asset Management LLC now owns 733,952 shares of the company's stock valued at $27,663,000 after purchasing an additional 129,621 shares in the last quarter. 98.59% of the stock is owned by hedge funds and other institutional investors.

Vital Farms Company Profile

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.